Back

Association between seasonal depressive symptoms and major adverse cardiovascular events: the potential mediating effect of systemic immune-inflammation index trajectories in patients with CAD

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Depression and heart disease Depression and Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mrs Yini Wang

The Second Affiliated Hospital of Harbin Medical University, Harbin (China)

5 More presentations in this session

Presentation thumbnail
Efficacy of an online psychological intervention for patients with ischemic heart disease targeting anxiety and depression: a randomized controlled trial (eMindYourHeart)
Doctor C. Helmark (Roskilde, DK)
Abstract
Presentation thumbnail
Temporal trajectories, proteomic mechanisms, and risk prediction of cardiometabolic disease and depression multimorbidity
Doctor W. Bao (Shanghai, CN)
Abstract
Presentation thumbnail
Association between depressive symptoms and hypertension care cascade in the Peruvian population
Professor A. Hernandez (Storrs, US)
Abstract
Presentation thumbnail
Predictive value of life’s crucial 9 for all-cause mortality and cardiovascular disease: an analysis of the PURE-China cohort study
Doctor J. Hao (Nanchang, CN)
Abstract
Presentation thumbnail
Depressive symptoms as a sex-specific predictor of physical performance development in cardiac rehabilitation
Professor B. Schmitz (Ennepetal, DE)
Abstract

Access the full session

Session thumbnail
Depression and heart disease

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Seasonal influence on acute coronary syndrome: a single-center study
21 March 2026
thumbnail
Webinar
Common mechanisms of mood disorders and cardiovascular disease
23 September 2024
thumbnail
Congress Presentation
Prognostic value of vascular inflammation biomarkers over clinical risk factors for cardiovascular risk : a meta-analysis
17 April 2021
thumbnail
Congress Presentation
Efficacy and safety of selective serotonin reuptake inhibitors on cardiovascular outcomes of patients with post-acute coronary syndrome depression: a systematic review and meta-analysis
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources